Clinical Trials Directory

Trials / Unknown

UnknownNCT02440217

Myocardial Metabolism in Patients With Dilated Cardiomyopathy

Abnormal Glucose Tolerance is Associated With a Reduced Myocardial Metabolic Flexibility in Patients With Dilated Cardiomyopathy

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Azienda Ospedaliero, Universitaria Pisana · Academic / Other
Sex
All
Age
21 Years – 69 Years
Healthy volunteers
Not accepted

Summary

Dilated cardiomyopathy (DCM) is characterized by a metabolic shift from fat to carbohydrates and failure to increase myocardial glucose uptake in response to workload increments. The investigators aimed at verifying whether this pattern is influenced by the presence of abnormal glucose tolerance (AGT).

Detailed description

A catheter is advanced into the coronary sinus by fluoroscopy to withdraw venous blood. A unipolar pacing catheter is positioned into the right atrium. Arterial sampling is done from the femoral artery introducer catheter. The study protocol consisted of 3 steps (Rest, Pacing and Recovery), during which timed blood samples are collected to measure plasma NEFA and glucose. After the instrumentation is completed, Rest arterio-venous sampling is performed at time -15 min and 0 min. After the 0 min, heart rate is increased by atrial pacing to 110 bpm for 3 minutes and to 130 bpm for 3 additional minutes and arterio-venous sampling is repeated at the end of each step (at time 3 and 6 min). Pacing is then stopped and at time 1, 5, 15 and 30 min into the Recovery period other pairs of arterial and venous samples are withdrawn.

Conditions

Timeline

Start date
2015-05-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-05-12
Last updated
2015-05-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02440217. Inclusion in this directory is not an endorsement.